Hiv fusion inhibitor peptides with improved biological...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/16 (2006.01) A61K 38/16 (2006.01) C07K 1/02 (2006.01) C07K 1/04 (2006.01) C07K 7/08 (2006.01) C12N 15/49 (2006.01) C40B 40/10 (2006.01)

Patent

CA 2651793

Provided is an HIV fusion inhibitor peptide having an amino acid sequence of any one of SEQ ID NO:9. SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO: 15; and provided is a pharmaceutical composition comprising a HIV fusion inhibitor peptide and one or more of a pharmaceutically acceptable carrier and macromolecular carrier, and uses and methods of treatment provided by these compositions.

L'invention concerne un peptide inhibiteur de la fusion du VIH ayant une séquence d'acide aminé parmi l'une des SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, ou SEQ ID NO: 15; et elle concerne aussi une composition pharmaceutique qui comprend un peptide inhibiteur de fusion du VIH, et un ou plusieurs porteurs pharmaceutiquement acceptables et un porteur macromoléculaire, et des utilisations et des méthodes de traitement conférées par ces compositions.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hiv fusion inhibitor peptides with improved biological... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hiv fusion inhibitor peptides with improved biological..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hiv fusion inhibitor peptides with improved biological... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1963141

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.